Mass screening for atrial fibrillation using ECG together with heart failure biomarker does not prevent ischaemic stroke or systemic embolism (blood clot) in older adults aged 75-76 years over 5 years follow-up, according to late breaking research presented in a Hot Line Session at this year’s ESC Congress 2024 in London, UK (30 Aug – 2 Sept).
Theratechnologies hit with FDA refusal to file letter for intramuscular version of HIV drug
Theratechnologies was hit with a second setback from the FDA this year as the agency handed down a refusal to file letter for the company’s
February 28, 2024